and Cashman, J.R., 2008
Our approach helps you understand how alcohol affects your mind, body, and habits
Patients who are considering stopping should discuss a structured exit plan with their physician, including whether transitioning to a different medication class, reducing to a lower maintenance dose, or pursuing a concurrent behavioral or endoscopic intervention might reduce the probability of rapid regain
Additional Research On GLP-1, Semaglutide, and Alcohol This newly published clinical trial is part of a small, but growing, body of evidence suggesting that GLP-1 receptor agonists like semaglutide may affect substance use behaviors
Statistical analysis A sample size of 361 participants per treatment arm was calculated to provide 85% power to jointly confirm the superiority of oral semaglutide (14 mg and 7 mg) vs sitagliptin 100 mg and the non-inferiority of oral semaglutide 3 mg vs sitagliptin 100 mg in reducing HbA 1c at week 26 for the trial product estimand
Doctors and researchers are approaching this topic with cautious optimism